+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Diabetes Diagnostics Market - Global Forecast 2026-2032- Product Image
Diabetes Diagnostics Market - Global Forecast 2026-2032- Product Image
New

Diabetes Diagnostics Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 199 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5887858
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The diabetes diagnostics market is undergoing dynamic transformation, driven by emerging clinical practices, advanced technologies, and evolving business models. Senior decision-makers navigating this sector must adapt strategies to successfully deliver stronger care experiences and operational outcomes in an increasingly complex environment.

Market Snapshot: Diabetes Diagnostics Market Growth and Outlook

The diabetes diagnostics market is projected to grow from USD 36.44 billion in 2025 to USD 39.71 billion in 2026 and to reach USD 72.43 billion by 2032, with a CAGR of 10.31%. Key drivers of this growth include continuous improvements in sensor technology, expanded use of continuous glucose monitoring systems, and strategic value chain adaptations that extend innovation throughout procurement, distribution, and care delivery pathways. As healthcare stakeholders focus on cost management and value-based care, the sector is seeing increased integration of monitoring and diagnostic solutions, supporting both clinical and operational decision-making.

Scope & Segmentation of the Global Diabetes Diagnostics Market

This analysis provides structured insight into the critical segments and regions influencing diabetes diagnostics adoption and long-term innovation. Senior leaders can leverage this segmentation to inform targeted investment and market-entry strategies:

  • Product Types: Blood Glucose Meters, parsed into desktop and portable formats, offer varying deployment options. Continuous Glucose Monitoring Systems, including both intermittent scanning and real-time capabilities, support diverse monitoring needs. HbA1c Test Kits are available for both lab-based and point-of-care testing. Lancets span lancing devices and single-use models, and test strips enable broad accessibility for routine patient monitoring.
  • End Users: Diagnostic Laboratories, Home Care Settings, Hospitals & Clinics, and Research Institutes each present unique operational requirements and purchasing drivers when selecting diabetes diagnostic solutions.
  • Distribution Channels: Hospital Pharmacies, Online Pharmacies (inclusive of e-commerce platforms and retailer websites), Retail Pharmacies, and Wholesale Distributors determine market reach and responsiveness to changing buyer behavior.
  • Test Technology: Invasive, Minimally Invasive, and Noninvasive modalities address differing levels of user comfort, validation requirements, and adoption hurdles in both professional and consumer settings.
  • Regions: Americas, Europe, Middle East & Africa, and Asia-Pacific regions reflect local differences in regulatory policy, infrastructure, and market priorities, each shaping the pathway for technology adoption and product rollout.

Segment-specific insight enables effective resource allocation and supports tailored go-to-market strategies across the diabetes diagnostics market landscape.

Key Takeaways for Strategic Decision-Makers

  • Integrated device and software platforms are creating value by supporting comprehensive patient management and enhancing clinical outcomes through seamless data sharing in connected care settings.
  • Advances in minimally invasive and noninvasive test technologies are increasing home-based testing adoption, making diabetes monitoring more accessible outside traditional healthcare facilities.
  • Manufacturers are prioritizing supply chain resilience and expanding regional manufacturing, adapting procurement and sourcing strategies to ensure consistent supply and predictable costs.
  • Greater emphasis on interoperability with electronic health records and digital care pathways is fueling institutional adoption, as organizations require easy integration to minimize clinical workflow interruptions.
  • Flexible regulatory and reimbursement ecosystems are driving collaboration between device manufacturers and digital health firms, enabling faster market access for new software-enabled and hybrid diagnostic products.

Tariff Impact and Strategic Localization

Changes to United States trade policy on medical device tariffs are prompting organizations to reassess sourcing, procurement, and partnership operations. Companies are responding to tariff impacts by recalculating landed costs, optimizing logistics, and adjusting inventory management approaches. These dynamics are accelerating the importance of localized manufacturing and stable supply chains, encouraging robust supplier vetting and regulatory compliance to maintain cost control and continuous innovation.

Market Research Methodology & Data Sources

This report utilizes a mixed-methods approach combining primary interviews with clinical, regulatory, and procurement specialists along with secondary validation through peer-reviewed literature and regulatory documentation. Methodological rigor is ensured through technology assessment, scenario analysis, and detailed supply chain mapping, supporting balanced and actionable insights for executive decision-making.

Why This Report Matters for Senior Stakeholders

  • Provides actionable intelligence on technology evolution, emerging market drivers, and critical growth segments within the diabetes diagnostics sector.
  • Equips leaders to mitigate procurement risks and manage operational complexity by detailing regulatory, reimbursement, and supply chain factors across major global regions.
  • Enables informed investment prioritization by highlighting the intersection of product, partnership, and commercial innovation opportunities, supporting competitive differentiation.

Conclusion

The future of the diabetes diagnostics market will be shaped by advances in technology, smart supply chain strategies, and tailored commercial models. Senior decision-makers who align initiatives with evolving market and regulatory needs are positioned to drive stronger outcomes and sustained leadership in this dynamic sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Diabetes Diagnostics Market, by Product Type
8.1. Blood Glucose Meters
8.1.1. Desktop Meters
8.1.2. Portable Meters
8.2. Continuous Glucose Monitoring Systems
8.2.1. Intermittent Scanning Continuous Glucose Monitoring
8.2.2. Real-Time Continuous Glucose Monitoring
8.3. Hba1c Test Kits
8.3.1. Lab-Based
8.3.2. Point-Of-Care
8.4. Lancets
8.4.1. Lancing Devices
8.4.2. Single-Use Lancets
8.5. Test Strips
9. Diabetes Diagnostics Market, by Test Technology
9.1. Invasive
9.2. Minimally Invasive
9.3. Noninvasive
10. Diabetes Diagnostics Market, by End User
10.1. Diagnostic Laboratories
10.2. Home Care Settings
10.3. Hospitals & Clinics
10.4. Research Institutes
11. Diabetes Diagnostics Market, by Distribution Channel
11.1. Hospital Pharmacies
11.2. Online Pharmacies
11.2.1. E-Commerce Platforms
11.2.2. Retailer Websites
11.3. Retail Pharmacies
11.4. Wholesale Distributors
12. Diabetes Diagnostics Market, by Region
12.1. Americas
12.1.1. North America
12.1.2. Latin America
12.2. Europe, Middle East & Africa
12.2.1. Europe
12.2.2. Middle East
12.2.3. Africa
12.3. Asia-Pacific
13. Diabetes Diagnostics Market, by Group
13.1. ASEAN
13.2. GCC
13.3. European Union
13.4. BRICS
13.5. G7
13.6. NATO
14. Diabetes Diagnostics Market, by Country
14.1. United States
14.2. Canada
14.3. Mexico
14.4. Brazil
14.5. United Kingdom
14.6. Germany
14.7. France
14.8. Russia
14.9. Italy
14.10. Spain
14.11. China
14.12. India
14.13. Japan
14.14. Australia
14.15. South Korea
15. United States Diabetes Diagnostics Market
16. China Diabetes Diagnostics Market
17. Competitive Landscape
17.1. Market Concentration Analysis, 2025
17.1.1. Concentration Ratio (CR)
17.1.2. Herfindahl Hirschman Index (HHI)
17.2. Recent Developments & Impact Analysis, 2025
17.3. Product Portfolio Analysis, 2025
17.4. Benchmarking Analysis, 2025
17.5. 3M Company
17.6. Abbott Laboratories
17.7. Acon Laboratories, Inc.
17.8. AgaMatrix, Inc.
17.9. Apex Biotechnology Corporation
17.10. ARKRAY, Inc.
17.11. B. Braun Melsungen AG
17.12. Beckman Coulter, Inc.
17.13. Becton, Dickinson and Company
17.14. Bio-Rad Laboratories, Inc.
17.15. Danaher Corporation
17.16. Diabetomics, Inc.
17.17. Diazyme Laboratories Inc
17.18. F. Hoffmann-La Roche Ltd.
17.19. ICON PLC
17.20. Medtronic PLC
17.21. Menarini Group
17.22. Nova Biomedical Corporation
17.23. Prestige Diagnostics
17.24. Sanwa Kagaku Kenkyusho Co, Ltd.
17.25. Siemens Healthineers AG
17.26. Sinocare, Inc.
17.27. Terumo Corporation
17.28. Tosoh Bioscience, Inc.
17.29. Trinity Biotech PLC
List of Figures
FIGURE 1. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL DIABETES DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL DIABETES DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 12. CHINA DIABETES DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY DESKTOP METERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY DESKTOP METERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY DESKTOP METERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY PORTABLE METERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY PORTABLE METERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY PORTABLE METERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY INTERMITTENT SCANNING CONTINUOUS GLUCOSE MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY INTERMITTENT SCANNING CONTINUOUS GLUCOSE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY INTERMITTENT SCANNING CONTINUOUS GLUCOSE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY REAL-TIME CONTINUOUS GLUCOSE MONITORING, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY REAL-TIME CONTINUOUS GLUCOSE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY REAL-TIME CONTINUOUS GLUCOSE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY LAB-BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY LAB-BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY LAB-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY POINT-OF-CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY LANCING DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY LANCING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY LANCING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY SINGLE-USE LANCETS, BY REGION, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY SINGLE-USE LANCETS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY SINGLE-USE LANCETS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY TEST STRIPS, BY REGION, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY TEST STRIPS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY TEST STRIPS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY MINIMALLY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY MINIMALLY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY MINIMALLY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY NONINVASIVE, BY REGION, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY NONINVASIVE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY NONINVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY E-COMMERCE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY E-COMMERCE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY RETAILER WEBSITES, BY REGION, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY RETAILER WEBSITES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY RETAILER WEBSITES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY RETAIL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY WHOLESALE DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY WHOLESALE DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY WHOLESALE DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 90. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 91. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 92. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2032 (USD MILLION)
TABLE 93. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 94. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2032 (USD MILLION)
TABLE 95. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2032 (USD MILLION)
TABLE 96. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 97. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 98. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 99. AMERICAS DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 101. NORTH AMERICA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 102. NORTH AMERICA DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 104. NORTH AMERICA DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2032 (USD MILLION)
TABLE 105. NORTH AMERICA DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2032 (USD MILLION)
TABLE 106. NORTH AMERICA DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 107. NORTH AMERICA DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 108. NORTH AMERICA DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 109. NORTH AMERICA DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 110. LATIN AMERICA DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 111. LATIN AMERICA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 112. LATIN AMERICA DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2032 (USD MILLION)
TABLE 113. LATIN AMERICA DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 114. LATIN AMERICA DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2032 (USD MILLION)
TABLE 115. LATIN AMERICA DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2032 (USD MILLION)
TABLE 116. LATIN AMERICA DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 117. LATIN AMERICA DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 118. LATIN AMERICA DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 119. LATIN AMERICA DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2032 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2032 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2032 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 130. EUROPE DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. EUROPE DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 132. EUROPE DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2032 (USD MILLION)
TABLE 133. EUROPE DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 134. EUROPE DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2032 (USD MILLION)
TABLE 135. EUROPE DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2032 (USD MILLION)
TABLE 136. EUROPE DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 137. EUROPE DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 138. EUROPE DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 139. EUROPE DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 140. MIDDLE EAST DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. MIDDLE EAST DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 142. MIDDLE EAST DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2032 (USD MILLION)
TABLE 143. MIDDLE EAST DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 144. MIDDLE EAST DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2032 (USD MILLION)
TABLE 145. MIDDLE EAST DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2032 (USD MILLION)
TABLE 146. MIDDLE EAST DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 147. MIDDLE EAST DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 148. MIDDLE EAST DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 149. MIDDLE EAST DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 150. AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 152. AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2032 (USD MILLION)
TABLE 153. AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 154. AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2032 (USD MILLION)
TABLE 155. AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2032 (USD MILLION)
TABLE 156. AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 157. AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 158. AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 159. AFRICA DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 161. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 162. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2032 (USD MILLION)
TABLE 163. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 164. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2032 (USD MILLION)
TABLE 165. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2032 (USD MILLION)
TABLE 166. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 167. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 168. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 169. ASIA-PACIFIC DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 171. ASEAN DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. ASEAN DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 173. ASEAN DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2032 (USD MILLION)
TABLE 174. ASEAN DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 175. ASEAN DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2032 (USD MILLION)
TABLE 176. ASEAN DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2032 (USD MILLION)
TABLE 177. ASEAN DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 178. ASEAN DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 179. ASEAN DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 180. ASEAN DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 181. GCC DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 182. GCC DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 183. GCC DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2032 (USD MILLION)
TABLE 184. GCC DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 185. GCC DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2032 (USD MILLION)
TABLE 186. GCC DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2032 (USD MILLION)
TABLE 187. GCC DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 188. GCC DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 189. GCC DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 190. GCC DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 191. EUROPEAN UNION DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 192. EUROPEAN UNION DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 193. EUROPEAN UNION DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2032 (USD MILLION)
TABLE 194. EUROPEAN UNION DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 195. EUROPEAN UNION DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2032 (USD MILLION)
TABLE 196. EUROPEAN UNION DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2032 (USD MILLION)
TABLE 197. EUROPEAN UNION DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 198. EUROPEAN UNION DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 199. EUROPEAN UNION DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 200. EUROPEAN UNION DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 201. BRICS DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 202. BRICS DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 203. BRICS DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2032 (USD MILLION)
TABLE 204. BRICS DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 205. BRICS DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2032 (USD MILLION)
TABLE 206. BRICS DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2032 (USD MILLION)
TABLE 207. BRICS DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 208. BRICS DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 209. BRICS DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 210. BRICS DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 211. G7 DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 212. G7 DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 213. G7 DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2032 (USD MILLION)
TABLE 214. G7 DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 215. G7 DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2032 (USD MILLION)
TABLE 216. G7 DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2032 (USD MILLION)
TABLE 217. G7 DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 218. G7 DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 219. G7 DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 220. G7 DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 221. NATO DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 222. NATO DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 223. NATO DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2032 (USD MILLION)
TABLE 224. NATO DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 225. NATO DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2032 (USD MILLION)
TABLE 226. NATO DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2032 (USD MILLION)
TABLE 227. NATO DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 228. NATO DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 229. NATO DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 230. NATO DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 231. GLOBAL DIABETES DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 232. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 233. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 234. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2032 (USD MILLION)
TABLE 235. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 236. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2032 (USD MILLION)
TABLE 237. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2032 (USD MILLION)
TABLE 238. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 239. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 240. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 241. UNITED STATES DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)
TABLE 242. CHINA DIABETES DIAGNOSTICS MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 243. CHINA DIABETES DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 244. CHINA DIABETES DIAGNOSTICS MARKET SIZE, BY BLOOD GLUCOSE METERS, 2018-2032 (USD MILLION)
TABLE 245. CHINA DIABETES DIAGNOSTICS MARKET SIZE, BY CONTINUOUS GLUCOSE MONITORING SYSTEMS, 2018-2032 (USD MILLION)
TABLE 246. CHINA DIABETES DIAGNOSTICS MARKET SIZE, BY HBA1C TEST KITS, 2018-2032 (USD MILLION)
TABLE 247. CHINA DIABETES DIAGNOSTICS MARKET SIZE, BY LANCETS, 2018-2032 (USD MILLION)
TABLE 248. CHINA DIABETES DIAGNOSTICS MARKET SIZE, BY TEST TECHNOLOGY, 2018-2032 (USD MILLION)
TABLE 249. CHINA DIABETES DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 250. CHINA DIABETES DIAGNOSTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 251. CHINA DIABETES DIAGNOSTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Diabetes Diagnostics market report include:
  • 3M Company
  • Abbott Laboratories
  • Acon Laboratories, Inc.
  • AgaMatrix, Inc.
  • Apex Biotechnology Corporation
  • ARKRAY, Inc.
  • B. Braun Melsungen AG
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Diabetomics, Inc.
  • Diazyme Laboratories Inc
  • F. Hoffmann-La Roche Ltd.
  • ICON PLC
  • Medtronic PLC
  • Menarini Group
  • Nova Biomedical Corporation
  • Prestige Diagnostics
  • Sanwa Kagaku Kenkyusho Co, Ltd.
  • Siemens Healthineers AG
  • Sinocare, Inc.
  • Terumo Corporation
  • Tosoh Bioscience, Inc.
  • Trinity Biotech PLC

Table Information

Report AttributeDetails
No. of Pages199
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 39.71 Billion
Forecasted Market Value ( USD ) by 2032 $ 72.43 Billion
Compound Annual Growth Rate10.3%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Diabetes Diagnostics - Global Strategic Business Report - Product Image

Diabetes Diagnostics - Global Strategic Business Report

  • Report
  • 346 Pages
  • Global
From
Diabetes Associated Ophthalmic Treatment Market - Global Forecast 2026-2032 - Product Image

Diabetes Associated Ophthalmic Treatment Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Diabetes Insulin Pumps Market - Global Forecast 2026-2032 - Product Image

Diabetes Insulin Pumps Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Disposable Diabetes Lancets Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Disposable Diabetes Lancets Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 186 Pages
  • Global
From
Diabetes Management Supplements Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Diabetes Management Supplements Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 82 Pages
  • Global
From

About the Diabetes Diagnostics Market

The Diabetes Diagnostics market is a subset of the Diagnostics industry, which focuses on the detection and diagnosis of diabetes. This market includes products and services used to detect and diagnose diabetes, as well as to monitor and manage the disease. These products and services include glucose meters, test strips, lancets, insulin pumps, continuous glucose monitoring systems, and other diabetes management tools. The Diabetes Diagnostics market is driven by the increasing prevalence of diabetes, the growing awareness of the disease, and the increasing demand for better management of the disease. Additionally, technological advancements in diabetes diagnostics have enabled the development of more accurate and efficient diagnostic tools. Some of the major companies in the Diabetes Diagnostics market include Abbott Laboratories, Roche Diagnostics, Johnson & Johnson, Bayer AG, and Medtronic. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.